Merck (MRK) Tops Q2 EPS by 10c; narrows forecast
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $144.30 +0.34%
Revenue Growth %: +0.2%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
TAYD, PKE, More
Revenue Growth %: +0.2%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q2 EPS of $2.13, $0.10 better than the analyst estimate of $2.03. Revenue for the quarter came in at $15.81 billion versus the consensus estimate of $15.87 billion.
GUIDANCE:
Merck sees FY2025 EPS of $8.87-$8.97, versus the consensus of $8.87. Merck sees FY2025 revenue of $64.3-65.3 billion, versus the consensus of $64.9 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US government plans $4 billion loan to Vistra for nuclear upgrades - Bloomberg
- Copper Lake Resources closes first tranche of private placement
- Rivian reports record Q3 deliveries, beats estimates, shares rise
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
